지난 2월에는 건일제약이 슈퍼 항생제 '큐비신'의 복제약 '답토마이신주' 허가를 받았으나 아직 미출시 상태다.
In February, Gunil Pharmaceutical Co. received permission to "Daptomycin injection" a clone of the super antibiotic "Cubicin," but it has yet to be released.